Key result
Lower skeletal muscle density is linked to ~20% higher cardiac valve calcification risk in dialysis.
Why the study?
Assessing muscle characteristics may improve cardiovascular risk stratification, but the relationship between muscle characteristics and cardiac valve calcification remains unclear.
Is low skeletal muscle density associated with an increased risk of cardiac valve calcification in dialysis patients?
Cross-Sectional (n=2,140)
Yes
Is low skeletal muscle density associated with an increased risk of cardiac valve calcification in dialysis patients?
Low skeletal muscle density, but not muscle mass, is independently associated with cardiac valve calcification in dialysis patients, suggesting muscle quality assessment could improve cardiovascular risk stratification.
Answers are grounded in this paper and cite their sources.
Muscle characteristics may inform CVC risk in dialysis patients; hypothesis-generating and requires prospective validation before clinical consideration.
Assessing muscle characteristics is an emerging field for improving stratification of cardiovascular disease risks. However, the relationship between muscle characteristics and cardiac valve calcification (CVC) remains unclear. This study evaluated how muscle mass and muscle quality relate to the risk of CVC in dialysis patients. This study included dialysis patients from four centers in China who underwent chest computed tomography (CT) and echocardiography. Skeletal muscle index (SMI) and skeletal muscle density (SMD) were measured by opportunistic chest CT at the first lumbar vertebra level to assess muscle mass and muscle quality. Patients were categorized by calcified valves: no calcification, single-valve (aortic or mitral) calcification, and dual-valve calcification. Ordinal logistic regression assessed the relationships of SMI and SMD with CVC risk. Of 2,140 patients (mean age of 55 years, 58.8% male), 782 (36.5%) exhibited CVC: 550 (25.7%) with single-valve calcification, and 232 (10.8%) with dual-valve calcification. As SMD quartiles decreased, the ORs (95% CIs) for CVC consistently increased (1.22 [0.90–1.64], 1.46 [1.08–1.97], 1.49 [1.07–2.08]; P = 0.003) after adjusting for potential confounders. The OR (95% CI) for CVC associated with a 1 SD decrease in SMD was 1.20 (1.06–1.36; P = 0.004) in Model 3. Multivariable adjustments revealed no significant links between SMI and CVC risk. In this large multicenter study, we found that low SMD, but not low SMI, is independently associated with CVC in dialysis patients. Integrating SMD assessments into routine care may improve CVC management for this population.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) conducted a cross-sectional in Dialysis patients (n=2,140). Low skeletal muscle density (SMD) vs. Higher skeletal muscle density was evaluated on Cardiac valve calcification (CVC) (OR 1.20, 95% CI 1.06-1.36, p=0.004). A 1 standard deviation decrease in skeletal muscle density was independently associated with a higher risk of cardiac valve calcification (OR 1.20) in dialysis patients.
Synapse has enriched 10 related papers. Consider them for comparative context: